{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T14:35:46Z","timestamp":1783780546508,"version":"3.55.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2008,5,29]],"date-time":"2008-05-29T00:00:00Z","timestamp":1212019200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur J Nucl Med Mol Imaging"],"published-print":{"date-parts":[[2008,9]]},"DOI":"10.1007\/s00259-008-0828-8","type":"journal-article","created":{"date-parts":[[2008,5,28]],"date-time":"2008-05-28T12:45:22Z","timestamp":1211978722000},"page":"1636-1641","source":"Crossref","is-referenced-by-count":66,"title":["Cardiac 123I-metaiodobenzylguanidine imaging allows early identification of dementia with Lewy bodies during life"],"prefix":"10.1007","volume":"35","author":[{"given":"Montserrat","family":"Estorch","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valle","family":"Camacho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pilar","family":"Paredes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabet","family":"Rivera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ato","family":"Rodr\u00edguez-Revuelto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Albert","family":"Flotats","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaume","family":"Kulisevsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ignasi","family":"Carrio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2008,5,29]]},"reference":[{"key":"828_CR1","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S1474-4422(03)00619-7","volume":"3","author":"IG McKeith","year":"2004","unstructured":"McKeith IG, Mintzer J, Aarsland D, et al. Dementia with Lewy bodies. Lancet Neurol 2004;3:19\u201328.","journal-title":"Lancet Neurol"},{"key":"828_CR2","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1136\/jnnp.74.6.720","volume":"74","author":"T Rahkonen","year":"2003","unstructured":"Rahkonen T, Eloniemi-Sulkava U, Rissanen S, Vatanen A, Viramo P, Sulkava R. Dementia with Lewy bodies according to the consensus criteria in a general population aged 75\u00a0years or older. J Neurol Neurosurg Psychiatry 2003;74:720\u20134.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"828_CR3","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1212\/WNL.47.5.1113","volume":"47","author":"IG McKeith","year":"1996","unstructured":"McKeith IG, Galasko D, Kosaka K, et al. Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop. Neurology 1996;47:1113\u201324.","journal-title":"Neurology"},{"key":"828_CR4","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1002\/(SICI)1099-1166(199907)14:7<526::AID-GPS965>3.0.CO;2-0","volume":"14","author":"CA Luis","year":"1999","unstructured":"Luis CA, Barker WW, Gajaraj K, et al. Sensitivity and specificity of three clinical criteria for dementia with Lewy bodies in an autopsy-verified sample. Int J Geriatr Psychiatry 1999;14:526\u201333.","journal-title":"Int J Geriatr Psychiatry"},{"key":"828_CR5","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1212\/WNL.54.5.1050","volume":"54","author":"IG McKeith","year":"2000","unstructured":"McKeith IG, Ballard CG, Perry RH, et al. Prospective validation of consensus criteria for the diagnosis of dementia with Lewy bodies. Neurology 2000;54:1050\u20138.","journal-title":"Neurology"},{"key":"828_CR6","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1136\/bmj.305.6855.673","volume":"305","author":"IG McKeith","year":"1992","unstructured":"McKeith IG, Fairbairn A, Perry RH, Thomson P, Perry E. Neuroleptic sensitivity in patients with senile dementia with Lewy body type. BMJ 1992;305:673\u20138.","journal-title":"BMJ"},{"key":"828_CR7","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1016\/S0140-6736(00)03399-7","volume":"356","author":"IG McKeith","year":"2000","unstructured":"McKeith IG, Del Ser T, Spano P, et al. Efficacy of rivastigmin in dementia with Lewy bodies: a randomized, double-blind, placebo-controlled international study. Lancet 2000;356:2031\u20136.","journal-title":"Lancet"},{"key":"828_CR8","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1212\/01.wnl.0000187889.17253.b1","volume":"65","author":"IG McKeith","year":"2005","unstructured":"McKeith IG, Dickson DW, Lowe J, et al. Diagnosis and management of dementia with Lewy bodies. Third report of the DLB consortium. Neurology 2005;65:1863\u201372.","journal-title":"Neurology"},{"key":"828_CR9","first-page":"BP132","volume":"30","author":"E Bombardieri","year":"2003","unstructured":"Bombardieri E, Aktolun C, Baum RP, et al. 131I\/123I-Metaiodobenzylguanidine (MIBG) scintigraphy: procedure guidelines for tumour Imaging. Eur J Nucl Med Mol Imaging 2003;30:BP132\u20139.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"828_CR10","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0022-3956(75)90026-6","volume":"12","author":"MF Folstein","year":"1975","unstructured":"Folstein MF, Folstein SE, McHugh PR. Mini-mental state: a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12:189\u201398.","journal-title":"J Psychiatr Res"},{"key":"828_CR11","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/S1071-3581(95)80023-9","volume":"2","author":"M Estorch","year":"1995","unstructured":"Estorch M, Carrio I, Berna L, Lopez-Pousa J, Torres G. Myocardial iodine-labeled metaiodobenzylguanidine 123 uptake relates to age. J Nucl Cardio 1995;2:126\u201332.","journal-title":"J Nucl Cardio"},{"key":"828_CR12","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1007\/s00401-005-0995-7","volume":"109","author":"S Orimo","year":"2005","unstructured":"Orimo S, Amino T, Itoh Y, et al. Cardiac sympathetic denervation precedes neuronal loss in the sympathetic ganglia in Lewy body disease. Acta Neuropathol 2005;109:583\u20138.","journal-title":"Acta Neuropathol"},{"key":"828_CR13","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1136\/jnnp.67.2.189","volume":"67","author":"S Orimo","year":"1999","unstructured":"Orimo S, Ozawa E, Nakade S, Sugimoto T, Mizusawa H. (123)I-metaiodobenzylguanidine myocardial scintigraphy in Parkinson\u2019s disease. J Neurol Neurosurg Psychiatry 1999;67:189\u201394.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"828_CR14","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1212\/WNL.53.5.1020","volume":"53","author":"S Braune","year":"1999","unstructured":"Braune S, Reinhardt M, Schnitzer R, Riedel A, Lucking CH. Cardiac uptake of [123I]MIBG separates Parkinson\u2019s disease from multiple system atrophy. Neurology 1999;53:1020\u20135.","journal-title":"Neurology"},{"key":"828_CR15","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1007\/s002590050544","volume":"27","author":"J Taki","year":"2000","unstructured":"Taki J, Nakajima K, Hwang EH, et al. Peripheral sympathetic dysfunction in patients with Parkinson\u2019s disease without autonomic failure is heart selective and disease specific. Eur J Nucl Med 2000;27:566\u201373.","journal-title":"Eur J Nucl Med"},{"key":"828_CR16","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1002\/mds.10461","volume":"18","author":"F Courbon","year":"2003","unstructured":"Courbon F, Brefel-Courbon C, Thalamas C, et al. Cardiac MIBG scintigraphy is a sensitive tool for detecting cardiac sympathetic denervation in Parkinson\u2019s disease. Mov Disord 2003;18:890\u20137.","journal-title":"Mov Disord"},{"key":"828_CR17","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.jns.2004.02.018","volume":"220","author":"S Saiki","year":"2004","unstructured":"Saiki S, Hirose G, Sakai K, et al. Cardiac 123I-MIBG scintigraphy can assess the disease severity and phenotype of PD. J Neurol Sci 2004;220:105\u201311.","journal-title":"J Neurol Sci"},{"key":"828_CR18","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1007\/BF02984560","volume":"18","author":"J Taki","year":"2004","unstructured":"Taki J, Yoshita M, Yamada M, Tonami N. Significance of 123I-MIBG scintigraphy as a pathophysiological indicator in the assessment of Parkinson\u2019s disease and related disorders: it can be a specific marker for Lewy body disease. Ann Nucl Med 2004;18:453\u201361.","journal-title":"Ann Nucl Med"},{"key":"828_CR19","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1136\/jnnp.2004.037028","volume":"76","author":"H Nagayama","year":"2005","unstructured":"Nagayama H, Hamamoto M, Ueda M, Nagashima J, Katayama Y. Reliability of MIBG myocardial scintigraphy in the diagnosis of Parkinson\u2019s disease. J Neurol Neurosurg Psychiatry 2005;76:249\u201351.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"828_CR20","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1111\/j.1600-0404.2005.00526.x","volume":"113","author":"H Oka","year":"2006","unstructured":"Oka H, Mochio S, Yoshioka M, Morita M, Onouchi K, Inoue K. Cardiovascular dysautonomia in Parkinson\u2019s disease and multiple system atrophy. Acta Neurol Scand 2006;113:221\u20137.","journal-title":"Acta Neurol Scand"},{"key":"828_CR21","first-page":"71","volume":"41","author":"H Takatsu","year":"2000","unstructured":"Takatsu H, Nishida H, Matsuo H, et al. Cardiac Sympathetic denervation from the early stage of Parkinson\u2019s disease: clinical and experimental studies with radiolabeled MIBG. J Nucl Med 2000;41:71\u20137.","journal-title":"J Nucl Med"},{"key":"828_CR22","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1136\/jnnp.70.6.781","volume":"70","author":"H Watanabe","year":"2001","unstructured":"Watanabe H, Ieda T, Katayama T, et al. Cardiac (123)I-meta-iodobenzylguanidine (MIBG) uptake in dementia with Lewy bodies: comparison with Alzheimer\u2019s disease. J Neurol Neurosurg Psychiatry 2001;70:781\u20133.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"828_CR23","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1136\/jnnp.71.5.583","volume":"71","author":"M Yoshita","year":"2001","unstructured":"Yoshita M, Taki J, Yamada M. A clinical role for [(123)I]MIBG myocardial scintigraphy in the distinction between dementia of the Alzheimer\u2019s-type and dementia with Lewy bodies. J Neurol Neurosurg Psychiatry 2001;71:583\u20138.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"828_CR24","doi-asserted-by":"crossref","first-page":"686","DOI":"10.2169\/internalmedicine.42.686","volume":"42","author":"T Oide","year":"2003","unstructured":"Oide T, Tokuda T, Momose M, et al. Usefulness of [123I]metaiodobenzylguanidine ([123I]MIBG) myocardial scintigraphy in differentiating between Alzheimer\u2019s disease and dementia with Lewy bodies. Intern Med 2003;42:686\u201390.","journal-title":"Intern Med"},{"key":"828_CR25","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1007\/s00259-005-1921-x","volume":"33","author":"H Hanyu","year":"2006","unstructured":"Hanyu H, Shimizu S, Hirao K, et al. Comparative value of brain perfusion SPECT and [(123)I]MIBG myocardial scintigraphy in distinguishing between dementia with Lewy bodies and Alzheimer\u2019s disease. Eur J Nucl Med Mol Imaging 2006;33:248\u201353.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"828_CR26","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1212\/01.wnl.0000219640.59984.a7","volume":"66","author":"M Yoshita","year":"2006","unstructured":"Yoshita M, Taki J, Yokoyama K, et al. Value of 123I-MIBG radioactivity in the differential diagnosis of DLB from AD. Neurology 2006;66:1850\u20134.","journal-title":"Neurology"},{"key":"828_CR27","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1157\/13090655","volume":"25","author":"M Estorch","year":"2006","unstructured":"Estorch M, Camacho V, Fuertes J, et al. Dementia with Lewy bodies and Alzheimer\u2019s disease: differential diagnosis by cardiac sympathetic innervation MIBG imaging. Rev Esp Med Nucl 2006;25:229\u201335.","journal-title":"Rev Esp Med Nucl"},{"key":"828_CR28","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1159\/000095641","volume":"22","author":"H Hanyu","year":"2006","unstructured":"Hanyu H, Shimizu S, Hirao K, et al. The role of 123I-metaiodobenzylguanidine myocardial scintigraphy in the diagnosis of Lewy body disease in patients with dementia in a memory clinic. Dement Geriatr Cogn Disord 2006;22:379\u201384.","journal-title":"Dement Geriatr Cogn Disord"},{"key":"828_CR29","first-page":"1099","volume":"47","author":"K Kashihara","year":"2006","unstructured":"Kashihara K, Ohno M, Kawada S, Okumura Y. Reduced cardiac uptake and enhanced washout of 123I-MIBG in pure autonomic failure occurs conjointly with Parkinson\u2019s disease and dementia with Lewy bodies. J Nucl Med 2006;47:1099\u2013101.","journal-title":"J Nucl Med"},{"key":"828_CR30","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1159\/000095641","volume":"22","author":"H Hanyu","year":"2006","unstructured":"Hanyu H, Shimizu S, Hirao K, et al. The role of 123I-metaiodobenzylguanidine myocardial scintigraphy in the diagnosis of Lewy body disease in patients with dementia in a memory clinic. Dement Geriatr Cogn Disord 2006;22:379\u201384.","journal-title":"Dement Geriatr Cogn Disord"},{"key":"828_CR31","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1212\/WNL.56.5.643","volume":"56","author":"K Lobotesis","year":"2001","unstructured":"Lobotesis K, Fenwick JD, Phipps A, et al. Occipital hypoperfusion on SPECT in dementia with Lewy bodies but not AD. Neurology 2001;56:643\u20139.","journal-title":"Neurology"},{"key":"828_CR32","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1007\/s00259-002-0919-x","volume":"29","author":"J Pasquier","year":"2002","unstructured":"Pasquier J, Michel B, Brenot-Rossi I, Hasse-Sebbag N, Sauvan R, Gastaut JL. Value of 99mTc-ECD SPET for diagnosis of dementia with Lewy bodies. Eur J Nucl Med 2002;29:1342\u20138.","journal-title":"Eur J Nucl Med"},{"key":"828_CR33","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1159\/000085070","volume":"20","author":"S Shimizu","year":"2005","unstructured":"Shimizu S, Hanyu H, Kanetaka H, Iwamoto T, Koizumi K, Abe K. Differentiation of dementia with Lewy bodies from Alzheimer\u2019s disease using brain SPECT. Dement Geriatr Cogn Disord 2005;20:25\u201330.","journal-title":"Dement Geriatr Cogn Disord"},{"key":"828_CR34","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1212\/WNL.51.1.125","volume":"51","author":"K Ishii","year":"1998","unstructured":"Ishii K, Imamura T, Sasaki M, et al. Regional cerebral glucose metabolism in dementia with Lewy bodies and Alzheimer\u2019s disease. Neurology 1998;51:125\u201330.","journal-title":"Neurology"},{"key":"828_CR35","first-page":"936","volume":"46","author":"RA Koeppe","year":"2005","unstructured":"Koeppe RA, Gilman S, Joshi A, et al. 11C-DTBZ and 18F-FDG PET measures in differentiating dementias. J Nucl Med 2005;46:936\u201344.","journal-title":"J Nucl Med"},{"key":"828_CR36","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1097\/MNM.0b013e328155d143","volume":"28","author":"PM Kemp","year":"2007","unstructured":"Kemp PM, Hoffmann SA, Tossici-Bolt L, Fleming JS, Holmes C. Limitations of the HMPAO SPECT appearances of occipital lobe perfusion in the differential diagnosis of dementia with Lewy bodies. Nucl Med Commun 2007;28:451\u20136.","journal-title":"Nucl Med Commun"},{"key":"828_CR37","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1136\/jnnp.73.2.134","volume":"73","author":"Z Walker","year":"2002","unstructured":"Walker Z, Costa DC, Walker RWH, et al. Differentiation of dementia with Lewy bodies from Alzheimer\u2019s disease using a dopaminergic presynaptic ligand. J Neurol Neurosurg Psychiatry 2002;73:134\u201340.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"828_CR38","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/S1474-4422(07)70057-1","volume":"6","author":"I McKeith","year":"2007","unstructured":"McKeith I, O\u2019Brien J, Walker Z, et al. Sensitivity and specificity of dopamine transporter imaging with 123I-FP-CIT SPECT in dementia with Lewy bodies: a phase III, multicentre study. Lancet Neurol 2007;6:305\u201313.","journal-title":"Lancet Neurol"},{"key":"828_CR39","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1136\/jnnp.2006.110122","volume":"78","author":"Z Walker","year":"2007","unstructured":"Walker Z, Jaros E, Walker RW, et al. Dementia with Lewy bodies: a comparison of clinical diagnosis, FP-CIT SPECT imaging and autopsy. J Neurol Neurosurg Psychiatry 2007;78:1176\u201381.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"828_CR40","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.2967\/jnumed.107.042143","volume":"48","author":"Y Inui","year":"2007","unstructured":"Inui Y, Toyama H, Manabe Y, et al. Evaluation of probable or possible dementia with Lewy bodies using 123I-IMP brain perfusion SPECT, 123I-MIBG, and 99mTc-MIBI myocardial SPECT. J Nucl Med 2007;48:1641\u201350.","journal-title":"J Nucl Med"}],"container-title":["European Journal of Nuclear Medicine and Molecular Imaging"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-008-0828-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00259-008-0828-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-008-0828-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,26]],"date-time":"2024-02-26T20:02:37Z","timestamp":1708977757000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00259-008-0828-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,5,29]]},"references-count":40,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2008,9]]}},"alternative-id":["828"],"URL":"https:\/\/doi.org\/10.1007\/s00259-008-0828-8","relation":{},"ISSN":["1619-7070","1619-7089"],"issn-type":[{"value":"1619-7070","type":"print"},{"value":"1619-7089","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,5,29]]}}}